This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Our programme takes a 'bench to bedside' approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer research.
This 13 week core course aims to:
One week of practical training is provided at the start of the course. This course is assessed through a lab notebook, group assessment, critical essay and an exam that focuses on data analysis and interpretation.
In the second semester, you can choose from a range of 3 week optional courses, before taking the core course “Designing a Research Project”.
In this 14 week core course you will:
Note: students must have a minimum of grade C in semesters 1 and 2 in order to proceed to the research project.
The knowledge and transferable skills developed in this programme will be suitable for those contemplating a PhD or further medical studies, those wishing to work in the health services sector, and those interested in working in the life sciences, biotechnology or pharmaceutical industries, including contract research organisations (CROs). This programme is designed for students with undergraduate degrees in the life sciences, scientists working in the pharmaceutical and biotechnology industries, and clinicians and other healthcare professionals.
The Cancer Sciences MRes is a one year, full time programme introduced to offer postgraduate training to suitably qualified science students who are interested in research careers in cancer. It is a stand-alone programme that would be of particular interest to students who wish to apply for further training at PhD level.
Designed to offer life and biomedical science graduates the opportunity to gain research training through practical experience in a leading cancer research centre.
The programme consists of three introductory taught modules and an extensive project within a research group in the School of Cancer Sciences. The lecture modules will be taught by leading cancer experts and will cover such topics as the cellular and molecular basis of cancer, the pathology of selected cancers and how translational research is applied to diagnosis and treatment of cancers. The projects will generally be laboratory-based and will provide skills in designing and implementing research strategies to answer fundamental questions relating to cancer causes, diagnosis and/or treatment.
The skills and experience gained will be of particular benefit when applying to PhD programmes in cancer studies and related cell and molecular biology subjects.
As a Birmingham student, you will be joining the academic elite and will have the privilege of learning from world-leading experts, as well as your peers. From the outset you will be encouraged to become an independent and self-motivated learner. We want you to be challenged and will encourage you to think for yourself.
You will have access to a comprehensive support system that will assist and encourage you, including personal tutors and welfare tutors who can help with both academic and welfare issues.
On completion of the MRes Cancer Sciences programme, students will have developed key research and presentation skills that are sought by many recruiters into further postgraduate study at PhD level. These skills will also be applicable to other career pathways in the biomedical and health sciences sectors.
Careers Support for Postgraduate Students
Careers Network – We can help you get ahead in the job market and develop your career
We recognise that as a postgraduate student you are likely to have specific requirements when it comes to planning for your next career step. Employers expect postgraduates to have a range of skills that exceed their subject knowledge. Careers Network offers a range of events and support services that are designed for all students, including postgraduates looking to find their niche in the job market. The Careers Network also have subject specific careers consultants and advisers for each College so you can be assured the information you receive will be relevant to your subject area. For more information visit the Careers Network website.
This course will focus on the physiology and pathology of blood and its use as a diagnostic and therapeutic tool. A variety of areas of molecular and cellular bioscience will be covered with an emphasis on new technologies and developments in Haematology and related disciplines such as Transfusion Science. You will expand your knowledge of the basic science and analytical techniques relating to Haematology and gain an up-to-date understanding of the application of Haematology in bioscience / pharmaceutical research, as well as in diagnostic and therapeutic medicine.
There will be an emphasis in the course on development of critical analysis skills in the assessment of scientific literature and laboratory data. In addition you will have the opportunity to design and execute your own research project. The course team is supported by visiting lecturers who are practising scientists in the field, which helps ensure that taught material is current and relevant.
The following modules are indicative of what you will study on this course.
The course is accredited by the Institute of Biomedical Science (IBMS).
As well as gaining specialist knowledge in Haematology and related disciplines, you will develop a range of transferable skills that will enhance your employment prospects and research opportunities in the UK or overseas.
The course is relevant to career pathways in diagnostic haematology, immunology and transfusion laboratories, research institutions and pharmaceutical companies.
The course will allow you to expand your understanding of immunology, immunopathology and immunotherapy, to further develop skills in analytical approaches to immunodiagnosis and molecular therapeutics, as well as enhance your competence in the design and execution of a laboratory based project. You will be able to take a proactive role in research, development, evaluation and implementation of current immunological techniques while perceiving the subject in the broader perspective of health care and scientific progress.
The scope of the modules included will ensure a breadth of knowledge appropriate for the scientific and professional needs of practising immunologists, at the same time making use of your knowledge and experience. This course is designed so that you can plan your own taught programme to match your interests and experience by combining core and optional modules with emphasis on therapeutics, diagnostics, haematology or public health.
The following modules are indicative of what you will study on this course.
The course is accredited by the Institute of Biomedical Science (IBMS).
The course has been designed to provide professionals with a broad range of skills in immunology, immunopathology and immunotherapy. Successful completion of the course will enhance your career prospects in education, in PhD programmes, in academia, research institutes, as well as in pharmaceutical and related industries. UK part-time students are normally employed in hospital or NHSBT laboratories or in research establishments.
You will develop a range of transferable skills that will enhance your employment prospects and research opportunities in the UK or overseas.
As an international student with experience in biomedical sciences, following completion of their studies, you will be able to return to your home country to pursue research opportunities or promotion, seek employment as research technician, biomedical scientist, scientific or medical technical officer or research assistant. You may also seek jobs in industry, research or healthcare or apply for further training (biomedical or clinical scientist routes).
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Further information on modules and degree structure is available on the department website: Cancer MSc
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
This MRes Advanced Biological Sciences lets you take your enthusiasm deeper with a research project carried out over a full calendar year supported by 4 modules that further develop your skills and knowledge.
The Institute of Integrative Biology
The Institute of Integrative Biology lies at the heart of a thriving science campus in Liverpool city centre. Based primarily in the Biosciences Building with additional sites at Leahurst Veterinary Field Station and Ness Botanic Gardens, we provide one of the most diverse, vibrant and integrated biosciences environments in the UK. The Institute comprises 220 staff (including 75 Principal Investigators) and 150 postgraduate students.
Research in the Institute spans the complete range of biological scales from genes and genetic regulation through proteins, post-translational modification and cellular function to whole organisms, populations and ecosystems. We use state-of-the-art “omics” technologies to generate large data-sets both within and across these scales. We also develop new mathematical and computational models to make sure we can fully exploit these data.
We have well established world-class research facilities that support scientists across all four of the Institute's research themes:
The facilities include the Centre for Genomic Research, the GeneMill Synthetic Biology Laboratory, the Centre for Proteome Research, the Computational Biology Facility, the Centre for Cell Imaging, NMR Centre for Structural Biology, the Barkla X-laboratory of Biophysics and the Henry Wellcome Laboratory of Mammalian Behaviour and Evolution.
Through our research partnerships with companies such as Unilever, strong global links into major research organisations in Europe, Japan, Brazil, USA and China and our scientific outreach to schools and the community, we are having true impact across the world. Our postgraduate students enjoy a first class experience with strong supervision and mentorship in an exciting research environment. Our Athena SWAN Gold award is evidence of our full commitment to providing opportunities for development to all, regardless of background or gender.
What is in the MRes Advanced Biological Sciences ?
This Master of Research programme is designed for those who want to move on to a research career. The programme consists of a 120 credit research project, during which you will work alongside PhD students and full-time researchers as a member of one of our research groups. This is supported by four 15 credit taught M-level modules. These include a compulsory module in research methods and their applications within the life sciences and a second taken from a selection that include statistics, programming for life sciences, professional & employability skills or bespoke skills development. The further two modules can include advanced taught modules in areas of animal behaviour, cancer biology, medical genetics, environmental biology, food security, microbiology, bioinformatics, biochemistry or statistics.
The result is bespoke pathways to MRes awards, affording applicants the opportunity to develop their own postgraduate degree programmes.
The taught modules take place in the autumn and spring semesters, alongside your initial work on your research project. In the summer semester you concentrate on your research.
These programmes can therefore be based around your particular areas of interest. The title of your degree award will reflect your pathway of choice.
Advanced Biological Sciences (Animal Sciences)
Advanced Biological Sciences (Bioinformatics)
Advanced Biological Sciences (Biotechnology)
Advanced Biological Sciences (Cell Signalling)
Advanced Biological Sciences (Chemical Biology)
Advanced Biological Sciences (Conservation Biology)
Advanced Biological Sciences (Evolution and Behavioural Biology)
Advanced Biological Sciences (Food Security)
Advanced Biological Sciences (Functional and Comparative Genomics)
Advanced Biological Sciences (Host: Parasite Biology)
Advanced Biological Sciences (Microbiology)
Advanced Biological Sciences (Molecular Oncology)
Advanced Biological Sciences (Plant Sciences)
Advanced Biological Sciences (Structural Biology)
Advanced Biological Sciences (Post-Genomic Sciences)
You will be able to choose from a series of taught modules to ensure that you develop the academic background and skills to excel in research.
Non-native English speakers are offered support in communication skills. This is taught by members of The University's English Language Unit and is designed to improve your English in a scientific context.
From molecules to humans, individuals to ecosystems, our research programmes – and scientists – are making a difference. Join us on the journey.
The MSc in Cancer Medicine will provide students with new knowledge of how precision medicine can improve and shape future healthcare. Students will gain hands-on experience of molecular techniques and the equipment/devices used in a modern molecular laboratory; the course will provide training in laboratory and research skills that are applicable across multiple scientific disciplines in a supportive learning environment. Students will be able to evaluate how novel therapeutic approaches can be used to stratify patients into treatment groups for better clinical management (stratified / precision medicine). They will observe the delivery of precision medicine through tours of the Northern Ireland Cancer Centre.
There are optional modules in the second semester allowing students to explore.the fundamental principles of Carcinogenesis and the translational approaches (including cutting edge technologies) which allow cancer scientists and clinicians to advance our understanding and treatment of cancers. The Precision Cancer Medicine stream provides a comprehensive overview of the current understanding of the Hallmarks of Cancer from the role of genetic/epigenetic alterations, cell cycle control and metastases/angiogenesis to the development of applications to help diagnose cancers earlier, improve treatments, rationally design clinical trials and reduce chemotherapy drug resistance.
The Radiation Oncology stream will develop skills in understanding the biological principles of radiotherapy and its clinical applications in the treatment of cancer. This will include the physical and chemical basis of radiation interactions and the biological consequences of radiation exposures. Clinical aspects of Radiation Oncology will be covered including principle of advanced radiotherapy delivery, cancer imaging techniques and biomarker discovery.
Importantly, both streams show how our improved understanding of the molecular processes driving cancer growth and spread can be ‘translated’ through research-intensive MSc projects to improve the treatment and survival of cancer patients.
The strong links between us and the biotech and biopharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.
WORLD CLASS FACILITIES
INTERNATIONALLY RENOWNED EXPERTS
Research Translational: from Concept to Commercialisation (Full Year)
Diagnosis and Treatment (Semester 1)
Cancer Biology (Semester 1)
Students will make a selection from the following modules:
Building on the biological basis of radiotherapy, this module will develop knowledge and skills in understanding clinical radiotherapy and medical imaging. Through the delivery of a multidisciplinary taught programme, students will cover clinical tumour and normal tissue biology, radiological imaging and the design of radiotherapy treatment plans. This will develop the clinical rationale for radiotherapy in the treatment of cancer and highlight emerging treatment combinations and techniques for biomarker discovery in radiation oncology.Biology and Imaging
You will undertake a project in the Centre for Cancer Research and Cell Biology.
This module comprises the write-up contribution to the overall research element of the programme, with the Research Project (SCM 8067). The Dissertation will represent the student’s personal studies in the literature, a description of their experimental execution of their project, data presentation, analysis and interpretation, followed by critical discussion and conclusions.
This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.
The programme is designed to provide you with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and provides an expert view of the available cancer medicines and the development of new cancer therapies.
It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT, communication, and time management) and research techniques. The taught component of the course provides the in depth knowledge and skills necessary to work in cancer research, and is delivered across 2 semesters through lectures, workshops, practicals and 1-to-1 tutorials with ICT staff. You will then join one of our research teams to complete the MSc research project.
"I've had a really good time at Bradford. It has taught me a lot and provided me with a lot of good skills so that I am best prepared for the future. I have already got a job as a Physician Associate and I believe doing my Master's here helped me get this job."
Harpreet Singh Bains, MSc Cancer Pharmacology, 2015
The Cancer Pharmacology programme is designed to provide you with ‘state of the art’ learning opportunities in modern cancer pharmacology, focussed on the cancer biology of target and biomarker identification and validation, development of preclinical screening programmes in silico, in vitro and in vivo, mechanisms of anticancer drug action, pharmacodynamics and pharmacokinetics.
It meets the demands of employers and students at taught postgraduate level, and has a strong track record in graduates progressing to employment in the field or PhD study.
A wide variety of teaching methods appropriate to the learning outcomes of the individual modules are employed throughout the programme; formal lectures from ICT research/teaching staff and visiting clinicians and industrial researchers, small group workshops and discussions with peers, laboratory practicals, journal clubs, group and one-to-one tutorials, and a large component of individual research. These are supported by material provided on Blackboard, the virtual learning environment, provided by the University. Students will also attend the Institute of Cancer Therapeutics Research Seminar programme. Self-directed independent learning forms a significant component at MSc level; students will be supported to develop the attributes and skills needed for life-long learning and continued professional development. Directed private study will involve you in a variety of activities, which include directed reading of selected textbooks and specified source literature, Blackboard (directed Web-based materials), report writing, preparing presentations to deliver to your peers, and other assignments.
Many students go on to study for PhDs either at Bradford or elsewhere.
Recent graduates are studying at Dundee, Newcastle and Glasgow universities, and at medical schools in the UK and abroad.
Those in employment are in research and development, clinical research and teaching roles.
The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.
Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
Graduates from this course will have a breadth and depth of cancer-focused training that will make them credible candidates to start or further a career within the health sector or research establishments.
This one year, full-time MSc course is designed to provide you with advanced knowledge, understanding and skills in the rapidly advancing field of Cancer Biology and Therapeutics.
Our aim is to provide you with a breadth and depth of cancer-focused training that will make you a highly attractive candidate to start or continue a career within the healthcare sector and public/private sector research establishments.
Throughout the course, you’ll gain from advanced teaching in the cellular aspects of cancer biology together with the molecular mechanisms underlying cancer development and progression. Through this programme you’ll also receive in-depth training in cancer therapeutics, encompassing biomarkers and diagnosis, therapeutic targets, drug discovery and clinical trials and chemo/radio therapy.
The course offers research skills training and a laboratory-based research project that helps you to develop research hypotheses and critically evaluate translational approaches with respect to the development of contemporary cancer therapeutics.
So, whether you’re looking to better prepare yourself for doctoral research or to achieve a self-contained advanced qualification in its own right, this postgraduate programme will give you a balanced combination of theory and practice to suit your needs and set you in excellent stead for your future career.
Distinctive features of the course include:
How will I be taught?
The programme will provide advanced teaching in the cellular aspects of cancer biology together with the molecular mechanisms underlying cancer development and progression. In-depth training will be provided in the area of cancer therapeutics, encompassing biomarkers and diagnosis, therapeutic targets, drug discovery and clinical trials and chemo/radio therapy, in addition to developing the student’s theoretical and practical research skills.
How will I be assessed?
Assessment for the course will comprise a combination of exams, written essays, posters, laboratory coursework and case studies.
Once you graduate from this course, you’ll gain a breadth and depth of cancer-focused training that could make you a highly attractive candidate to start or continue a career within the healthcare sector and research establishments.
Potential employment opportunities include studying for a PhD, becoming a medical laboratory science officer or research technician, clinical trials co-ordinator, medical writer or scientific liaison officer.
Improved global life expectancy has resulted in a cancer epidemic. It is well recognised that accurate early diagnosis is an essential aspect of the administration of increasingly expensive and tailored cancer treatment care plans.
The Biomedical Sciences (Cancer Biology) MSc programme has been devised to provide knowledge of key aspects of this increasingly important disease area.
You will become familiar with the genetic and cellular changes occurring in both solid and blood-borne cancers, the current and emerging technological approaches for diagnosis of the disease and the effect on pertinent cellular changes on patient prognosis. Studies on populations and the influence of genotypic variation will ensure that you are qualified to make sense of cancer statistics.
You are able to tailor your programme by selecting from a menu of option modules and pursuing a research project in an area ranging from molecular through to cellular or tissue-based aspects of cancer.
During the course you will join our thriving research environment and will have access to excellent laboratory facilities within the Faculty. On successful completion of the course you will be equipped to take forward your career with an in-depth knowledge of this increasingly common disease area.
The course is accredited by the Institute of Biomedical Science (IBMS).
The Cancer Biology MSc equips students for careers in the research sector, for example in academia or in the biotechnology or pharmaceutical industries.
Depending on the options that are taken by the student, in addition to their in-depth knowledge of molecular and cellular changes that occur in cancer, the student may also gain a detailed knowledge of the –OMICs topics alongside immunodiagnostics and immunotherapeutics. These areas of study open up the choices that students may select in terms of careers.
Our alumni have gone on to study PhDs or have gone on to work in the biotechnology industries in drug discovery roles.